
Tema Cardiovascular and Metabolic ETF
Tema Cardiovascular and Metabolic ETF (HRTS) Price & Chart
HRTS ETF Chart & Stats
- Day’s Range
- $38.77 - $39.49
- 52-Week Range
- $32.59 - $39.92
- Previous Close
- $39.24
- Volume
- 2,500
- Average Volume (3M)
- 2,183
- AUM
- 57.71M
- NAV
- 39.22
- Expense Ratio
- 0.75%
- Holdings Count
- 47
- Beta
- 0.60
- Inception Date
- Nov 21, 2023
- Last Dividend Ex-Date
- Dec 10, 2025
- Dividend Yield
- (1.22%)
- Shares Outstanding
- 1,480,000
- Standard Deviation
- N/A
ETF Overview
Tema Cardiovascular and Metabolic ETF
The Tema Cardiovascular and Metabolic ETF (Ticker: HRTS) is a specialized exchange-traded fund designed to provide investors with targeted exposure to the innovative and rapidly evolving sectors within the health care industry. Focusing on the Pharma, Biotech & Life Sciences niche, this ETF is dedicated to companies at the forefront of cardiovascular and metabolic health advancements. It seeks to capture the growth potential of firms pioneering treatments, technologies, and research aimed at combating prevalent health issues such as heart disease, diabetes, and other metabolic disorders. By investing in HRTS, investors gain access to a curated portfolio of leading-edge companies that are shaping the future of health care, driving significant improvements in patient outcomes, and potentially transforming the landscape of medical science. This sector-focused ETF is an ideal choice for those looking to capitalize on the intersection of healthcare innovation and market opportunity in the cardiovascular and metabolic domains.
- Asset Class
- Equity
- Region
- Global
- Issuer
- Tema
- Index Tracked
- No Underlying Index
- Ticker Symbol
- HRTS
HRTS ETF News




HRTS ETF FAQ
What was HRTS’s price range in the past 12 months?
What is the AUM of HRTS?
Is HRTS overvalued?
Does HRTS pay dividends?
How many shares outstanding does HRTS have?
HRTS ETF Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| LLYEli Lilly And Company | 12.63% |
| TMOThermo Fisher Scientific | 5.31% |
| RHHBYRoche Holding AG | 4.32% |
| MRKMerck & Company | 4.19% |
| KODKodiak Sciences | 4.05% |
| BBIOBridgebio Pharma | 3.69% |
| GILDGilead Sciences | 3.39% |
| RVMDRevolution Medicines, Inc. | 3.26% |
| DHRDanaher Corporation | 3.10% |
| UNHUnitedhealth Group Inc. | 3.07% |
| Total | 47.01% |









